For research, professional, and investigational evaluation only. No exosome product is FDA-approved for therapeutic use in humans.

Biological materials · research compounds

Evaluate the material.
Not the marketing.

B&H Bio supplies documented exosome materials and research compounds with batch-linked quality records available for professional review.

USP <71>Sterility criterion
USP <85>Endotoxin criterion
21 CFR 1271Donor eligibility
Lot-linkedDocumentation review

Quality system

Records that stay attached to the lot.

A useful quality file answers what was tested, how it was tested, which lot it covers, and whether the result met the stated criterion.

  • Identity and characterizationReview the method, reported result and product-specific limitations.
  • Safety criteriaSterility and endotoxin entries should name the method and acceptance criterion.
  • TraceabilityThe product identifier, lot number and report must be reconcilable.

A clear path to review

Decide. Explore. Request.

01 / Decide

Set the standard

Use the COA guide to define what a complete, lot-specific documentation package should contain.

02 / Explore

Review materials

Browse real product families and the verified specifications available for each.

03 / Request

Ask for the lot

Request the current documentation for the material or compound under evaluation.

Documentation available

Start with the records.

Tell us what you are evaluating. We will match the request to the relevant current-batch documentation.

Request documentation